Part D Brand And Generic Drug Price Increase Reviews Planned By HHS IG
This article was originally published in The Pink Sheet Daily
Executive Summary
Brand price increases will be compared to rate of inflation in study slated for FY 2017 completion; table provides overview of ongoing studies on Rx drugs covered by Medicare and Medicaid or regulated under 340B.